Ipsen

NCT00234520

A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide

NCT00210431

Post Marketing Surveillance Study of Dysport

NCT00455728

A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders

NCT00455884

A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency

NCT00747604

IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex

NCT00500227

Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery

NCT00686348

Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study

NCT00747500

Non Interventional Post Marketing Programme in Acromegaly

NCT00710307

Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study)

NCT00903110

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

NCT00747786

Non Interventional Post Marketing Programme in Neuroendocrine Tumours

NCT00833196

Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia

NCT01020500

To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke

NCT01234168

A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

NCT01333384

Study in Polish Acromegalic Patients Treated With Somatuline Autogel

NCT01239628

A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke

NCT01314365

DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia

NCT01351051

A Study of the Potential Risk Factors Linked to the Development of Severe Forms of Endometriosis

NCT01354405

Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)

NCT01444794

Adult Subjects Suffering From Lower Limb Spasticity Following Stroke

NCT01383863

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer

NCT03586063

Study of Diphereline 3.75 mg Treatment In Women Suffering From Internal Genital Endometriosis

NCT01471405

One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma

NCT01560858

Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State

NCT01840449

Somatuline Predictive Factors in Acromegaly and NET

NCT01676090

IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population

NCT01840462

Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]

NCT01753349

Phase IV-Cervical Dystonia-INTEREST IN CD2

NCT02231593

SAGIT for Classification of Patients With Acromegaly in Clinical Practice

NCT01840475

Arm Spasticity - Non-Interventional Study Early BIRD (BoNT Treatment: Initial and Repeated Documentation)

NCT03689673

Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)

NCT01819883

Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly

NCT02012036

Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice

NCT01942369

A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months

NCT02012127

Description of Sign-and-symptom Associations at Acromegaly Diagnosis.

NCT02238366

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer

NCT02789696

Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome

NCT02020967

Programme of Acromegaly Screening in Patients With Associated Somatic Disorders

NCT02853409

Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer

NCT02187679

Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's Syndrome

NCT02630654

Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs

NCT02020980

RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke

NCT02321449

The Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over

NCT02321475

EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders

NCT02275312

ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Limb Spasticity

NCT02020499

Predictive Factors Study

NCT02353897

Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®

NCT02384330

Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke

NCT03329872

Neuro-Orthopedic Registry of the University Hospital of Toulouse

NCT02396966

Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.

NCT02454803

Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice

NCT02444494

Study to Document the Effectiveness of Dysport in Patients Suffering From Upper Limb Spasticity (ULS) After Stroke

NCT02390206

Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients

NCT02539927

Validation Study of the SAGIT® Instrument in Acromegaly

NCT02542501

Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues

NCT02630641

Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone.

NCT02630680

Eziclen Drug Utilisation in Real Life Setting

NCT02730104

Community-based Neuroendocrine Tumor (NET) Research Study

NCT02698384

Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg

NCT02788565

Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours

NCT02853422

Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours

NCT02788578

A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours

NCT02807233

Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects

NCT03043586

Treatment Patterns and Treatment Outcomes for Acromegaly

NCT03017729

Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity

NCT03112694

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

NCT03017690

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

NCT03017313

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients

NCT03220087

Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain

NCT03209960

Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity

NCT03516110

Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy

NCT03419572

Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma

NCT03442660

Validation of the Spasticity Related Quality of Life Questionnaire

NCT03562091

Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel

NCT03647878

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

NCT03846687

Validation of Patient Reported Outcome Measures for Use in Hallux Valgus

NCT03744585

Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.

NCT03696407

A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK

NCT03770169

Validation of Patient Reported Outcome Measures for Use in Vulvodynia

NCT03699579

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

NCT04673240

CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY

NCT03776123

Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

NCT03947762

Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.

NCT03995524

Spasticity and Treatment Satisfaction Among Stroke Survivors

NCT03895463

Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice

NCT04510688

Spanish Real-World Evidence Cabozantinib

NCT04050527

Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort

NCT04353765

Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors

NCT04106349

Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)

NCT04649632

Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database.

NCT04003519

Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly

NCT04365023

Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors

NCT04340336

Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A

NCT04560101

Motor and Non-motor Symptoms in Cervical Dystonia

NCT04624828

Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT

NCT04609800

Study on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France.

NCT04637204

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

NCT04593420

Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

NCT04396704

A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity.

NCT04665323

An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.

NCT04604379

A Study to Review Treatment Outcomes From Treatment With Dysport® Injections in Adults for Upper and/or Lower Limb Focal Spasticity

NCT04446702

Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA

NCT04649580

United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting

NCT04957160

Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination

NCT05169775

A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).

NCT05224349

Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.

NCT05377684

Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment

NCT05431803

Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China

NCT05184504

Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American

NCT05444933

A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.

NCT05546190

A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)

NCT05361434

A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults

NCT05326620

National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)

NCT05184231

Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China

NCT06217770

Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment

NCT05759273

A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy

NCT05752825

Acromegaly: Balance, Falls and Fracture Risk

NCT05922579

A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET

NCT06258902

Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

NCT06055725

A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development

NCT06245772

CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity

NCT06548867

Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib

NCT06253897

A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly

NCT06447168

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

NCT06089616

A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT06850038

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

NCT06446609

Drug-induced Liver Injury: Itching Study

NCT07049887

A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)

NCT07185919

A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

NCT07191704

A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain